CXCL2 and neoplasm: Expression of the CXCR2 ligands CXCL1 and CXCL2, known to be downstream of MAPK and NF-κB signaling [22, 35], correlated with accumulation of CXCR2 positive gMDSC in the TME with tumor progression.